Table 1.
Comparison of patient groups who did and did not have an improvement in their quality of life pre and post treatment
| Grade of Effect size | Group | p Value | |
|---|---|---|---|
| SF-36 | |||
| Physical component | Small | BAD | 0.15 |
| Small | PC | 0.37 | |
| Small | CD | 0.26 | |
| Mental component | Moderate | BAD | *0.03 |
| Null | PC | 0.73 | |
| Moderate | CD | 0.07 | |
| EQ-5D-3L | |||
| Mobility | Null | BAD | 1.00 |
| Small | PC | 0.34 | |
| Small | CD | 0.17 | |
| Self-care | Small | BAD | 0.33 |
| Small | PC | 0.34 | |
| Small | CD | 0.34 | |
| Activity | Moderate | BAD | *0.002 |
| Small | PC | 0.44 | |
| Null | CD | 1.00 | |
| Pain & Discomfort | Small | BAD | 0.16 |
| Null | PC | 0.59 | |
| Moderate | CD | 0.10 | |
| Anxiety & Depression | Small | BAD | 0.06 |
| Small | PC | 0.19 | |
| Small | CD | 0.19 | |
| VAS | Null | BAD | 0.48 |
| Small | PC | 0.39 | |
| Small | CD | 0.26 | |
| IBDQ-32 | Moderate | CD | *0.03 |
Effect size was calculated by dividing the difference between baseline and post-treatment scores by the standard deviation of baseline scores, where effect sizes of > 0.2 was considered small, > 0.5 moderate and > 0.8 large. Null effect sizes are those who did not achieve any improvement in their quality of life scores. * denotes p < 0.05